About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

NCT00723021·4 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Persistent mild/moderate asthma for at least 6 months.
Reduced lung function
Reversible airway obstruction

You may not be if

Pregnant/nursing females.
Liver function tests greater than upper limit of normal (ULN)

The record

StatusCompleted

PhasePhase 2

Taking part15

StartedJul 2008

UpdatedFeb 1, 2013

Conditions

Where4

Pfizer Investigational Site
Baltimore, Maryland, United States
Pfizer Investigational Site
North Dartmouth, Massachusetts, United States
Pfizer Investigational Site
Kalamazoo, Michigan, United States

Clareo Health | PF-04191834 Single Dose Bronchodilatory Study In Asthma.